KRAS and cervical squamous intraepithelial neoplasia: CMS2 is driven by WNT and MYC pathway activation and is often associated with high chromosomal instability (CIN), while CMS3 exhibits metabolic reprogramming and frequent KRAS/PI3K mutations.